Cancer Research and Treatment

Amir-Hassan Zarnani

1 Article

Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect: Amir-Hassan Zarnani, Monireh Torabi-Rahvar, Mahmood Bozorgmehr, Mehri Zareie, Nazanin Mojtabavi; Cancer Res Treat. 2015;47(3):518-526. Published online November 27, 2014; DOI: https://doi.org/10.4143/crt.2013.241

Purpose
Targeted immunotherapy using dendritic cells (DCs) has been employed in numerous investigations aiming at combating neoplasms. We previously showed that copulsing of an antigen with a helper protein could considerably enhance antigen presenting capacity of ex vivo–generated DCs. In this study, we attempted to administer an effective treatment in a murine model of colon cancer with DCs pulsed with the mixture of a tumor-specific gp70-derived peptide (AH1) and a helper protein, ovalbumin (OVA). Materials and Methods First, the presence of gp70 in CT26 tumor cells and tumor tissues was verified using immunofluorescence and Western blot analyses. Next, DCs were purified from normal mice, loaded ex vivowith AH1 and OVA (DC-Pep-OVA), and injected into tumor-bearing mice. Tumor volume, in vitro antigen (Ag)-specific proliferation of splenic cells, and survival rate were measured to determine the efficacy of DC-Pep-OVA. As the control groups, tumor-bearing mice were vaccinated with DC-Pep, unpulsed DC, and DCs loaded with a mixture of OVA and an irrelevant peptide (P15), or were not vaccinated at all. Results DC-Pep-OVA showed superior efficacy over other groups, as indicated by smaller tumor volume, higher Ag-specific proliferation rate of splenic cells, and prolonged survival. Conclusion Overall, in the present study we showed for the first time that DCs copulsed with AH1 (tumor Ag) and OVA (helper molecule) could be considered as potentially robust weapons for use in future antitumor immunotherapies.

Citations

Citations to this article as recorded by

Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity
Hajer Fritah, Michele Graciotti, Cheryl Lai-Lai Chiang, Anne-Laure Huguenin- Bergenat, Rémy Petremand, Ritaparna Ahmed, Philippe Guillaume, Julien Schmidt, Brian J. Stevenson, David Gfeller, Alexandre Harari, Lana E. Kandalaft
iScience.2023; 26(4): 106288. CrossRef
Recent Advances in Antitumor Dendritic Cell Vaccines
Chunxia Ge, Xuelian Yang, Jiaxuan Xin, Xiangqian Gong, Xuhan Wang, Lijun Kong
Cancer Biotherapy and Radiopharmaceuticals.2023; 38(7): 450. CrossRef
T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity
Sang-Eun Lee, A-Ri Shin, Hyun-Jung Sohn, Hyun-Il Cho, Tai-Gyu Kim
Cancer Research and Treatment.2020; 52(3): 747. CrossRef
A Cross-Species Reactive TIGIT-Blocking Antibody Fc Dependently Confers Potent Antitumor Effects
Fang Yang, Linlin Zhao, Zhizhong Wei, Yajing Yang, Juan Liu, Yulu Li, Xinxin Tian, Ximing Liu, Xueyuan Lü, Jianhua Sui
The Journal of Immunology.2020; 205(8): 2156. CrossRef
Combination Treatment of Stereotactic Body Radiation Therapy and Immature Dendritic Cell Vaccination for Augmentation of Local and Systemic Effects
Chul Won Choi, Min Ho Jeong, You-Soo Park, Cheol-Hun Son, Hong-Rae Lee, Eun-Kyoung Koh
Cancer Research and Treatment.2019; 51(2): 464. CrossRef
Antitumor Effects of DC Vaccine With ALA-PDT-Induced Immunogenic Apoptotic Cells for Skin Squamous Cell Carcinoma in Mice
Haiyan Zhang, Peiru Wang, Xiaojie Wang, Lei Shi, Zhixia Fan, Guolong Zhang, Degang Yang, Cody F. Bahavar, Feifan Zhou, Wei R. Chen, Xiuli Wang
Technology in Cancer Research & Treatment.2018;[Epub] CrossRef
Cell separation: Potentials and pitfalls
Narges Rahmanian, Mohmood Bozorgmehr, Monir Torabi, Abolfazl Akbari, Amir-Hassan Zarnani
Preparative Biochemistry & Biotechnology.2017; 47(1): 38. CrossRef
Systemic delivery of complexes of melanoma RNA with mannosylated liposomes activates highly efficient murine melanoma-specific cytotoxic T cells in vivo
O. V. Markov, N. L. Mironova, E. V. Shmendel, M. A. Maslov, M. A. Zenkova
Molecular Biology.2017; 51(1): 102. CrossRef
A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
Ko-Jiunn Liu, Tsu-Yi Chao, Jang-Yang Chang, Ann-Lii Cheng, Hui-Ju Ch’ang, Woei-Yau Kao, Yu-Chen Wu, Wei-Lan Yu, Tsai-Rong Chung, Jacqueline Whang-Peng
Journal of Biomedical Science.2016;[Epub] CrossRef
Review on the Immunotherapy Strategies Against Metastatic Colorectal Carcinoma
Lucia Signorini, Serena Delbue, Pasquale Ferrante, Marco Bregni
Immunotherapy.2016; 8(10): 1245. CrossRef

12,836 View
152 Download
12 Web of Science
10 Crossref

Author index